Document is current
Any future updates will be listed below
-
Authors
Bubar, Kate M.
Middleton, Casey E.
Bjorkman, Kristen K. https://orcid.org/0000-0002-9540-6657
Parker, Roy https://orcid.org/0000-0002-8412-4152
Larremore, Daniel B. https://orcid.org/0000-0001-5273-5234
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1U01CA261277-01)
- License Information
-
More Information
Article History
Received: 14 January 2022
Accepted: 19 April 2022
First Online: 19 May 2022
Competing interests
: R.P. is a founder of Faze Therapeutics. D.B.L. is an advisor to Darwin BioSciences and has received consulting fees from iCareDx. All other authors declare no conflicts of interest.
